-
Kenya's economy faces climate change risks: World Bank
-
France's largest wildfire in decades 'under control', says minister
-
South Korea baseball league cancels two games over heatwave
-
Warsaw and Kyiv exhume Volyn victims at centre of diplomatic quarrel
-
India PM Modi says he forgives protesters who abused him
-
California lifeguards wiped out from extreme weather
-
US plans steep water cuts for southwest amid Colorado River crisis
-
Amazon surges as US stocks shrug off bond yield worries
-
Oil giants report blowout profits on war, warn high gas prices could persist
-
Hungary to shut nuclear plant as heatwave hits central Europe
-
Google launches new satellite image AI tool, alarming researchers
-
Tech-fuelled rally fizzles as oil prices rise
-
US Fed dissenters call for rate hikes over sustained inflation
-
Alarm over climate-linked low level of German waterways
-
New York sues online prediction markets giant Kalshi
-
Commerzbank agrees to talks with UniCredit after two-year standoff
-
Profits surge at US oil giant amid Iran war supply shock
-
Fornaro Legal Releases Guidance to Help Businesses Maintain Clear Ownership Records During Growth
-
Stock markets rally on tech rebound
-
Japan probe made closest-ever asteroid flyby: space agency
-
France, Spain assess scorched terrain as new wildfires threaten other regions
-
British oil giant BP aims to sell North Sea business
-
Chipmaker Kioxia reports AI-driven 45-fold surge in quarterly net profit
-
China factory activity slides as leaders seek spending boost
-
Far right and far left battle for power in polarised Berlin
-
Tech rebound fuels record-breaking rally in South Korean stocks
-
The last trio: S.Africa's zoo elephants await their fate
-
Cables and cooling bring AI windfall to Indian suppliers
-
Oil industry sees war windfall but girds for political blowback
-
Anthropic's models gained unauthorized 'real-world' access during testing
-
Amazon beats expectations with cloud and AI growth
-
Apple tops estimates in CEO Cook's final quarter, but shares fall
-
Blowout Microsoft results lift US stocks as oil retreats
-
Milei demands expulsion of foreigners expressing 'hate' against Argentina
-
'Beginning of the end': Relief but no party as French wildfire winds down
-
Italy's Po River valley on drought alert
-
Southern Europe 'becoming more flammable' in hotter climate, experts say
-
Prada profits pinched as growth hard to chase
-
Mammoth bones found on parched bed of Danube in Bulgaria
-
Stocks climb on earnings and rates, oil retreats
-
MEXC Lists Grvt (GRVT) with $60,000 Worth of GRVT and 10,000 USDT in Airdrop+ Rewards
-
US economic growth slows in second quarter, missing expectations
-
George and Amal Clooney flee French home due to wildfire
-
Russia adds Telegram founder Durov to 'terrorist' blacklist
-
MEXC Ventures Supports Alpha Arena's APAC Debut at Coinfest Bali
-
Stocks diverge on earnings, as oil steadies
-
AI data centre supplier Zhongji InnoLight slips on Hong Kong debut
-
Eurozone economy grows despite Middle East war
-
May, June heatwaves caused 2,877 extra deaths in England: govt
-
Singapore group will develop 'most promising' Ebola vaccine
Social media fuels surge in UK men seeking testosterone jabs
Social media claims by clinics promoting testosterone treatment for men to improve their physique and mood are driving large numbers to pay for unnecessary medication that can have serious side effects, doctors say.
Men's hormone levels can fluctuate for lifestyle reasons but many are being prescribed testosterone replacement therapy (TRT) without medical need despite the health risks, doctors in the UK and Australia told AFP.
Promotional campaigns by private clinics use social media and influencers, as well as an ad campaign in the London Underground, to encourage young body-conscious men to test their levels, claiming fatigue or irritation are symptoms.
"Do you wish you could have more energy? Less body fat? A higher sex drive?" asks one ad.
Costly treatments could be the answer.
The trend is now affecting the state-funded National Health Service, since many seek free treatment there.
The number of men referred to NHS specialists after being diagnosed privately "has really exploded", said Channa Jayasena, a professor of endocrinology at Imperial College.
"It's a huge problem for us, which is impacting our ability to treat other patients."
TRT is needed by those with true deficiency, known as hypogonadism, including men who never went through puberty or had testicular cancer.
But some clinics prescribe it to men with normal levels and risking side-effects including infertility and thickened blood that carries cardiovascular risks, doctors warn.
While private clinics are not obliged to disclose numbers, Jayasena estimated "hundreds of thousands" of men in the UK have accessed costly TRT privately.
And most "just don't need it at all", he said.
- Manosphere -
Isobelle Smith, an endocrinologist in New South Wales, Australia, has made Instagram videos debunking TRT claims.
"I've seen the advertising that up to one in four or one in five men before the age of 40 have testosterone deficiency -- that is just absolutely not true," she told AFP.
"These companies are saying that essentially normal levels are low," she said.
"Really, it's performance-enhancing drugs."
Some link the TRT craze to the "manosphere" culture with its fixation on bulging muscles and longevity.
Misogynist influencer Andrew Tate claims to have "high T" and berates men with "low T". US Health Secretary Robert F. Kennedy Jr. recently extolled President Donald Trump's high levels.
Data on private clinics is not available, but prescriptions for testosterone by family doctors rose 13 percent in 2024 in England, according to the Care Quality Commission regulator.
The NHS in England spent over £30 million ($40.1 million) in 2024 on testosterone jabs and gels, according to the OpenPrescribing website. Some were used for gender change and women's health.
Studies in the United States and Europe have shown testosterone levels declining for decades, which scientists link to lifestyle and environmental factors.
Despite the scepticism from medical professionals, men told AFP they had felt the positive effects of TRT.
Gavin McNamee, a 41-year-old personal trainer from northeast England, said he had had poor mental health and low energy. But after five months of treatment, he said: "I just feel so much better".
"I feel like a different person," agreed Carl Graham, a 38-year-old legal administrator from Liverpool on TRT for over six months.
Neither man consulted NHS doctors, and both inject testosterone prescribed privately, paying £100 to £200 a month.
- 'Take a test' -
Heavily-muscled influencers promote clinics offering TRT via gels, pills or injections.
Jayasena said images of "men with six-packs even in their 50s and 60s", such as Amazon founder Jeff Bezos, had great sway.
Advertising testosterone, like any prescription-only medicine, is illegal in the UK.
But private clinics circumvent this by advertising blood tests.
"Feeling tired, unfocused, or taking longer to recover after workouts? It could be time to check your testosterone levels," reads one ad for Harley Street TRT provider.
"If you don't feel like you're firing on all cylinders, take a test," ex-commando and television personality Jason Fox says in a video promoted by online provider Voy.
The ads appear to target young men, and Harley Street TRT has a "25 plus" setting on its Meta ads, offering personal trainers £50 per referral.
Each patient generates an "average £1,500 ($2,000) profit per year," it says.
H.Meyer--CPN